Larson, D L <br/><br/>
What is the appropriate management of tissue extravasation by antitumor agents?  [electronic resource] 

 -  Plastic and reconstructive surgery  Mar 1985 
 - 397-405 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0032-1052 
<br/><br/><label>Standard No.: </label>10.1097/00006534-198503000-00017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents--administration & dosage<br/>Daunorubicin--adverse effects<br/>Doxorubicin--adverse effects<br/>Extravasation of Diagnostic and Therapeutic Materials--etiology<br/>Female<br/>Humans<br/>Infusions, Parenteral<br/>Injections, Subcutaneous<br/>Male<br/>Middle Aged<br/>Mitomycins--adverse effects<br/>Skin Transplantation<br/>Vinblastine--adverse effects<br/>Vincristine--adverse effects<br/>Vindesine